Back

Adenovirus type 34 and HVR1-deleted Adenovirus type 5 do not bind to PF4: clearing the path towards vectors without thrombosis risk

Sallard, E.; Pembaur, D.; Schroeer, K.; Schellhorn, S.; Koukou, G.; Schmidt, N.; Zhang, W.; Kreppel, F.; Ehrhardt, A.

2022-11-07 microbiology
10.1101/2022.11.07.515483 bioRxiv
Show abstract

The adenoviral vector based AstraZeneca and Janssen COVID vaccines have been associated with rare cases of thrombosis, a condition which depends on adenovirus binding to the blood protein Platelet Factor 4 (PF4). In order to identify adenoviruses with low or absent affinity for PF4, we screened dozens of types from various adenovirus species, and Adenovirus type 5 (Ad5) derived vectors carrying genetic or chemical modifications of different hexon hyper-variable regions (HVR). For this purpose, we established an armamentarium of techniques including ELISA-qPCR and Aggregate Pull-Down (APD), which enabled fast and sensitive assessments of virus-protein interactions. Unlike most tested serotypes, Ad34 did not bind to PF4. Likewise, the deletion or shielding of the HVR1 loop of Ad5 seemingly ablated its PF4 binding. Therefore, we showed that PF4 binds to adenovirus hexon through interactions dependent on HVR1, and identified vectors that may avoid or decrease the risk of thrombosis and represent safer candidates for vaccine or gene therapy vector development.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Journal of Virology
● 499 papers in training set
Top 0.9%
8.7%
Similar papers in this journal
2
PLOS Pathogens
● 820 papers in training set
Top 2%
7.1%
Similar papers in this journal
3
Antiviral Research
○ 50 papers in training set
Top 0.1%
6.6%
Similar papers in this journal
4
mBio
● 833 papers in training set
Top 3%
6.6%
Similar papers in this journal
5
Viruses
○ 332 papers in training set
Top 0.9%
5.4%
Similar papers in this journal
6
Nature Communications
○ 5641 papers in training set
Top 28%
5.4%
7
Molecular Therapy
○ 81 papers in training set
Top 0.4%
4.7%
8
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 11%
4.7%
9
Journal of General Virology
● 53 papers in training set
Top 0.2%
4.0%
50% of probability mass above
10
Molecular Therapy - Methods & Clinical Development
○ 38 papers in training set
Top 0.2%
4.0%
11
Vaccines
○ 198 papers in training set
Top 1%
3.1%
12
Scientific Reports
○ 3612 papers in training set
Top 34%
3.1%
13
Science Advances
● 1243 papers in training set
Top 12%
3.1%
14
Nucleic Acids Research
◐ 1281 papers in training set
Top 7%
2.3%
15
Microbiology Spectrum
● 469 papers in training set
Top 6%
2.1%
16
eLife
● 5828 papers in training set
Top 46%
2.1%
17
eBioMedicine
○ 183 papers in training set
Top 3%
1.7%
18
iScience
○ 1154 papers in training set
Top 21%
1.5%
19
PLOS ONE
● 5266 papers in training set
Top 49%
1.5%
20
Emerging Microbes & Infections
○ 74 papers in training set
Top 1%
1.0%
21
PNAS Nexus
◐ 159 papers in training set
Top 4%
0.8%
22
Science Translational Medicine
● 127 papers in training set
Top 4%
0.8%
23
Communications Biology
○ 993 papers in training set
Top 32%
0.8%
24
Frontiers in Cellular and Infection Microbiology
○ 109 papers in training set
Top 4%
0.8%
25
mSphere
● 302 papers in training set
Top 7%
0.8%
26
Applied and Environmental Microbiology
● 339 papers in training set
Top 5%
0.8%
27
Cell Reports Medicine
○ 153 papers in training set
Top 5%
0.8%
28
Frontiers in Immunology
○ 638 papers in training set
Top 11%
0.6%
29
Molecular Therapy Methods & Clinical Development
○ 13 papers in training set
Top 0.2%
0.6%
30
Journal of Medical Virology
○ 140 papers in training set
Top 3%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.